Mevion Medical Systems

Mevion Medical Systems

Private
MassachusettsHealthcare & Life Scienceshttps://mevion.com/

Last Round

Growth Equity

6/14/2018

Total Funding Raised

$517.7M

Company Overview

Mevion Medical Systems is a medical equipment company that provides compact proton therapy systems for use in radiation treatment for cancer patients.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

proton therapy systemcompact proton therapyproton therapysingle-room proton therapyradiation oncologyMedTechpencil beam scanningsuperconducting synchrocyclotroncancer treatmentradiotherapy equipmentmedical capital equipmentparticle therapyRadOnc equipmentproton multi-leaf collimatorLINAC vaultequipment financing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Mevion Medical Systems Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Mevion Medical Systems Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Growth Equity6/14/2018
Private Equity8/4/2015
Convertible Debt8/1/2014
VC Round6/25/2013
Series D1/24/2012
Series C
3/1/2011

Key People

Founding team and executive leadership

Curt Kienast

Chief Operating Officer

Executive Team

Mevion Medical Systems Investors

Notable investors and investment history

InvestorRounds
CAM CapitalPrivate Equity
HOPU FundGrowth Equity, Private Equity
Yuan Ming CapitalPrivate Equity, Growth Equity
Caxton AssociatesConvertible Debt
Caxton Advantage Life Sciences Fund ISeries D
VenrockPrivate Equity, Series D, Series B, Series A, Convertible Debt, VC Round, Series C
China Everbright LimitedGrowth Equity

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 11, 2025

    Monthly visitors grew 69% MoM, reaching 8.6K.

  • Jun 14, 2018

    $150M round led by Yuan Ming Capital

Mevion Medical Systems Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Mevion Medical Systems Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Mevion Medical Systems's valuation, stock price, and market status.

Firmographic Details

HeadquartersMassachusetts
Employee Range236
Year Founded2004
Last Funding6/14/2018

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







DisclaimerAll investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.